Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a research report released on Saturday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Performance Eagle Pharmaceuticals stock opened at $0.85 on Friday. The company’s 50-day moving average is $0.84 and its 200-day moving […]
More Stories
Vistra Corp. (NYSE:VST) Shares Sold by Two Sigma Investments LP
Two Sigma Investments LP lowered its holdings in Vistra Corp. (NYSE:VST – Free Report) by 97.8% in the fourth quarter,...
Suvretta Capital Management LLC Purchases New Position in NVIDIA Co. (NASDAQ:NVDA)
Suvretta Capital Management LLC purchased a new stake in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) in the 4th...
Voloridge Investment Management LLC Raises Stock Holdings in WesBanco, Inc. (NASDAQ:WSBC)
Voloridge Investment Management LLC boosted its stake in WesBanco, Inc. (NASDAQ:WSBC – Free Report) by 32.6% during the 4th quarter,...
Second Line Capital LLC Acquires 12,530 Shares of NVIDIA Co. (NASDAQ:NVDA)
Second Line Capital LLC raised its holdings in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 65.1% during the 4th quarter,...
Scissortail Wealth Management LLC Increases Position in NVIDIA Co. (NASDAQ:NVDA)
Scissortail Wealth Management LLC lifted its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 113,240.7% during the...
Sculptor Capital LP Has $63.92 Million Holdings in NVIDIA Co. (NASDAQ:NVDA)
Sculptor Capital LP lifted its stake in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 43.4% in the 4th...